Issue 1, 2016

Gemcitabine and chlorotoxin conjugated iron oxide nanoparticles for glioblastoma therapy

Abstract

Many small-molecule anti-cancer drugs have short blood half-lives and toxicity issues due to non-specificity. Nanotechnology has shown great promise in addressing these issues. Here, we report the development of anti-cancer drug gemcitabine-conjugated iron oxide nanoparticles for glioblastoma therapy. A glioblastoma targeting peptide, chlorotoxin, was attached after drug conjugation. The nanoparticles have a small size (∼32 nm) and uniform size distribution (PDI ≈ 0.1), and are stable in biological medium. The nanoparticles effectively enter cancer cells without losing potency compared to the free drug. Significantly, the nanoparticles showed a prolonged blood half-life and the ability to cross the blood–brain barrier in wild type mice.

Graphical abstract: Gemcitabine and chlorotoxin conjugated iron oxide nanoparticles for glioblastoma therapy

Supplementary files

Article information

Article type
Communication
Submitted
12 Oct 2015
Accepted
24 Nov 2015
First published
24 Nov 2015

J. Mater. Chem. B, 2016,4, 32-36

Author version available

Gemcitabine and chlorotoxin conjugated iron oxide nanoparticles for glioblastoma therapy

Q. Mu, G. Lin, V. K. Patton, K. Wang, O. W. Press and M. Zhang, J. Mater. Chem. B, 2016, 4, 32 DOI: 10.1039/C5TB02123E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements